| ［1］ |
Hankinson SE，Eliassen AH.Endogenous estrogen，testosterone and progesterone level in relation to breast cancer risk［J］.J Natl Cancer Inst，2007，106（1/5）：1856-1865.
|
| ［2］ |
Janerich DT，Hoff MB.Evidence for a crossover in breast cancer risk［J］.Am J Epidemiol，1982，116（5）：737-742.
|
| ［3］ |
Sanderson M，Williams MA，Malone KE，et al.Perinatal factors and risk of breast cancer［J］.Epidemiology，1996，7（1）：34-37.
|
| ［4］ |
Willett W，Stampfer M.Dietary fat and the risk of breast cancer［J］.J Natl Cancer Inst，1989，81（1）：1422-1424.
|
| ［5］ |
Russo J，Russo IH.The role of estrogen in the initiation of breast cancer［J］.J Steroid Biochem Mol Biol，2006，102（1/5）：89-96.
|
| ［6］ |
Dai J，Jian J，Bosland M，et al.Roles of hormone replacement therapy and iron in proliferation of breast epithelial cells with different estrogen and progesterone receptor status［J］.Breast，2008，17（2）：172-179.
|
| ［7］ |
Yue W，Santen RJ，Wang JP，et al.Genotoxic metabolites of estradiol in breast：potential mechanism of estradiol induced carcinogenesis［J］.J Steroid Biochem Mol Biol，2003，86（3-5）：477-486.
|
| ［8］ |
Opatrny L，Dell'Aniello S，Assouline S，et al.Hormone replacement therapy use and variations in the risk of breast cancer［J］.BJOG，2008，115（2）：169-175.
|
| ［9］ |
Fournier A，Berrino F，Riboli E，et al.Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort［J］.IntJ Cancer，2005，114（3）：448-454.
|
| ［10］ |
Fournier A，Berrino F，Clavel-Chapelon F.Unequal risks for breast cancer associated with different hormone replacement therapies：results from the E3N cohort study［J］.Breast Cancer Res Treat，2008，107（1）：103-111.
|
| ［11］ |
Wiebe JP.Progesterone metabolites in breast cancer［J］.Endocr Relat Cancer，2006，13（3）：717-738.
|
| ［12］ |
Campagnoli C，Clavel Chapelon F，Kaaks R，et al.Progestins and progesterone in hormone replacement therapy and the risk of breast cancer［J］.J Steroid Biochem Mol Biol，2005，96（2）：95-108.
|
| ［13］ |
Rossouw JE，Anderson GL，Prentice RL，et al.Risks and benefits of estrogen plus progestin in healthy postmenopausal women：principal results From the Women's Health Initiative randomized controlled trial［J］.JAMA，2002，288（3）：321-333.
|
| ［14］ |
Million Women Study Collaborators.Breast cancer and hormonereplacement therapy：the million women Study［J］.Lancet，2003，362（9382）：419-427.
|
| ［15］ |
Burger H.Hormone replacement therapy in the post-Women's Health Initiative era［J］.Climacteric，2003，6（3）：11-36.
|
| ［16］ |
Tannen RL，Weiner MG，Xie D，et al.Estrogen affects postmenopausal women differently than estrogen plus progestin replacement therapy［J］.Hum Reprod，2007，22（6）：1769-1777.
|
| ［17］ |
Corrao G，Zambon A，Conti V，et al.Menopause hormone replacement therapy and cancer risk：an Italian record linkage investigation［J］.Ann Oncol，2008，19（1）：150-155.
|
| ［18］ |
Cortés-Prieto J，Juez-Martel P.Incidences of breast cancer throughout long-term hormone replacement therapy［J］.J S teroid Biochem，2007，104（3/5）：180-189.
|
| ［19］ |
Ravdin PM，Cronin KA，Howlader N，et al.The decrease in breast-cancer incidence in 2003 in the United States［J］.N Engl Med，2007，356（16）：1670-1674.
|
| ［20］ |
Jemal A，Ward E，Thun MJ.Recent trends in breast cancer incidence rates by age and tumor characteristics among US women［J］.Breast Cancer Res，2007，9（3）：28.
|
| ［21］ |
Robbins AS，Clarke CA.Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004［J］.J Clin Oncol，2007，25（23）：3437-3439.
|
| ［22］ |
Canfell K，Banks E，Moa AM，et al.Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia［J］.Med J Aust，2008，188（11）：641-644.
|
| ［23］ |
Katalinic A，Rawal R.Decline in breast cancer incidence after decrease in utilization of hormone replacement therapy［J］.Breast Cancer Res Treat，2008，107（3）：427-430.
|
| ［24］ |
Vankrunkelsven P，Kellen E，Lousbergh D，et al.Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg［J］.Breast Cancer Res Treat，2009，118（2）：425-432.
|
| ［25］ |
Canfell K，Banks E，Clements M，et al.Sustained lower rates of HRT prescribing and breast cancer incidence in Australia since 2003［J］.Breast Cancer Res Treat，2009，117（3）：671-673.
|
| ［26］ |
Suhrke P，Zahl PH，Maehlen J.Declining breast cancer incidence and decreased HRT use［J］.Lancet，2009，373（9662）：460-461.
|
| ［27］ |
Kerlikowske K，Miglioretti DL，Buist DS，et al.Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population［J］.J Natl Cancer Inst，2007，99（17）：1335-1339.
|
| ［28］ |
Trinh XB，Peeters F，Tjalma WA.The thoughts of breast cancer survivors regarding the need for starting hormonere placement therapy［J］.Eur J Obstet Gynecol Reprod Biol，2006，124（2）：250-253.
|
| ［29］ |
Holmberg L，Iversen OE，Rudenstam CM，et al.Increased risk of recurrence after hormone replacement therapy in breast cancer survivors［J］.J Natl CancerInst，2008，100（7）：475-482.
|
| ［30］ |
Rice S，Whitehead SA.Phytoestrogens oestrogen synthesis and breast cancer［J］.J Steroid Biochem Mol Biol，2008，108（3/5）：186-195.
|